Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Heritage Financial
HFWA
$1.18B
| $841K | ﹤0.01% |
47,084
-14,683
| -24% | -$254K |
|
|
SFUN
2352
CALL
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $841K | ﹤0.01% |
+2,000
| New | +$797K |
|
|
EBSB
2353
DELISTED
Meridian Bancorp, Inc.
EBSB
| $839K | ﹤0.01% |
62,584
-78,072
| -56% | -$1.01M |
|
|
VVUS
2354
DELISTED
Vivus Inc
VVUS
| $837K | ﹤0.01% |
35,476
-24,865
| -41% | -$610K |
|
2355
Kornit Digital
KRNT
$727M
| $836K | ﹤0.01% |
+60,724
| New | +$884K |
|
2356
Helen of Troy
HELE
$679M
| $834K | ﹤0.01% |
+8,554
| New | +$752K |
|
2357
Comstock Resources
CRK
$4.26B
| $833K | ﹤0.01% |
50,033
+32,383
| +183% | +$670K |
|
2358
VanEck Pharmaceutical ETF
PPH
$1.01B
| $833K | ﹤0.01% |
11,767
+2,639
| +29% | +$190K |
|
2359
Ardmore Shipping
ASC
$694M
| $832K | ﹤0.01% |
68,665
+32,269
| +89% | +$377K |
|
2360
Gladstone Investment Corp
GAIN
$653M
| $831K | ﹤0.01% |
104,471
+27,605
| +36% | +$210K |
|
|
TOO
2361
DELISTED
Teekay Offshore Partners L.P.
TOO
| $829K | ﹤0.01% |
40,964
+27,150
| +197% | +$604K |
|
|
LRFC
2362
DELISTED
Logan Ridge Finance Corp
LRFC
| $828K | ﹤0.01% |
+8,843
| New | +$919K |
|
|
BGG
2363
DELISTED
Briggs & Stratton Corp.
BGG
| $826K | ﹤0.01% |
42,874
-43,822
| -51% | -$858K |
|
|
ARNA
2364
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $824K | ﹤0.01% |
17,754
-164,155
| -90% | -$7.12M |
|
2365
Omega Healthcare
OHI
$14.2B
| $821K | ﹤0.01% |
23,921
-59,591
| -71% | -$2.19M |
|
2366
IDT Corp
IDT
$1.72B
| $816K | ﹤0.01% |
63,943
+1,841
| +3% | +$23.3K |
|
|
AVDL
2367
DELISTED
Avadel Pharmaceuticals
AVDL
| $812K | ﹤0.01% |
38,318
-1,793,542
| -98% | -$32.2M |
|
|
MTSN
2368
DELISTED
MATTSON TECHNOLOGY INC
MTSN
| $806K | ﹤0.01% |
240,541
-385,941
| -62% | -$1.42M |
|
2369
MGIC Investment
MTG
$6.42B
| $804K | ﹤0.01% |
70,666
-659,393
| -90% | -$7.04M |
|
|
TGP
2370
DELISTED
Teekay LNG Partners L.P.
TGP
| $804K | ﹤0.01% |
24,956
-3,383
| -12% | -$122K |
|
|
HIMX
2371
PUT
Himax Technologies
HIMX
$2.41B
| $803K | ﹤0.01% |
+100,000
| New | +$680K |
|
2372
HealthEquity
HQY
$8.73B
| $801K | ﹤0.01% |
25,000
-179,335
| -88% | -$4.81M |
|
|
MASI
2373
DELISTED
Masimo
MASI
| $799K | ﹤0.01% |
20,635
-227,504
| -92% | -$8.15M |
|
|
HIMX
2374
Himax Technologies
HIMX
$2.41B
| $798K | ﹤0.01% |
99,439
-745,228
| -88% | -$5.07M |
|
2375
Invesco S&P 500 Pure Value ETF
RPV
$1.75B
| $796K | ﹤0.01% |
14,862
-30,705
| -67% | -$1.69M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.